ArticleBMC cancer2025

Peripheral circulating proteomic profiling reveals serum CD80 is positively correlated with the efficacy of neoadjuvant PD-1 blockade combined with chemotherapy for esophagus cancer.

Liangliang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.